What are the contraindications to roselixizumab?

Rozanolixizumab (Rozanolixizumab) is a monoclonal antibody drug targeting immune system-related diseases. It is mainly used to treat myasthenia gravis (a rare disease). This drug helps control an overactive immune response by suppressing certain important immunoregulatory factors in the immune system. However, like many drugs, roselixizumab also has certain contraindications and usage restrictions, and patients need to pay special attention when using it.

First, the use of this drug is absolutely contraindicated in patients with a known history of allergy, especially to the components of roselixizumab. Allergic reactions may include skin allergies, difficulty breathing, facial swelling, urticaria, etc., and even severe allergic reactions may occur, threatening life safety. Therefore, before starting roselixizumab, it is important to confirm whether the patient is allergic to the drug or its components.

Secondly, rozelixizumab is also contraindicated in patients with severe immunodeficiency. Patients with already severely compromised immune systems, such as those receiving immunosuppressive therapy or with underlying immune system conditions, may be at higher risk for infection. The use of roselixizumab may further reduce a patient's immune defenses, leading to more severe infections. Therefore, this drug should be avoided in such patients unless there is a specific medical need and under close supervision by a physician.

Additionally, although roselixizumab is safe in most adult patients, caution is needed when using this drug in women who are pregnant or breastfeeding. Animal experiments have not found that the drug directly causes fetal harm, but there is currently insufficient clinical data to evaluate its impact on pregnant women and fetuses. Therefore, pregnant and breastfeeding women should avoid using this drug unless absolutely necessary. If it must be used during this period, the potential risks and benefits of its treatment need to be weighed and carried out under the guidance of a professional doctor.

Reference materials:https://www.drugs.com/rystiggo.html